Other successful methods focus on the direct delivery radation through interactions with an RNA-induced silencing complex (RISC). Here, a clear correlation beof siRNA into cells, and fidelity in cellular uptake of siRNA is the key to causing RNAi using this type of tween siRNA localization, cellular uptake, and RNAi activity was discovered by delivering siRNA into cells approach. Currently, the most often used method of siRNA delivery is Lipofectamine transfection; however, the use using siRNA-TAT 47-57 peptide, siRNA-TAT 47-57 -derived oligocarbamate conjugates, or nanoparticles. For sucof this approach is limited to specific cell types, and this procedure could be toxic to cells and animals [17]. cessful RNAi, the localization of siRNA was distinctly perinuclear, suggesting that siRNA is targeted to these Here, we describe the development of new strategies for functional siRNA delivery to cells using cell-permeregions for interactions with RISC to induce RNAi. siRNA sequence variation and the presence of the able peptides, unnatural biopolymers, and nanoparticles. We planned to explore siRNA delivery by the use target mRNA apparently did not change the subcellular localization pattern of siRNA. Intriguingly, siRNA con- plasmic compartments in the perinuclear region. We observed a strong correlation between siRNA cellular Once cleavage has occurred, target mRNA is degraded and RISC is recycled for another cleavage reaction [7] . uptake, RNAi activity, and siRNA localization. Because of its effectiveness in silencing specifically targeted genes, RNAi is a mechanism that is being exResults ploited for a variety of laboratory applications and future clinical therapeutics.
Can we silence cellular genes by using siRNA covalently linked with TAT peptide? To address this question, dyl 4-(p-maleimidophenyl)-butyrate. During this step, the NHS ester group of the crosslinker reacted with the we prepared TAT peptide siRNA conjugates to target CDK9, the cyclin-dependent kinase subunit of positive primary amino group at the 3Ј termini of the siRNA. Maleimide-activated siRNA were then purified using a transcription elongation factor P-TEFb [46] . As shown by Western blot analysis in Figure 3 , SS/AS-3Ј-TAT conreverse-phase column and were incubated with an equal molar ratio of TAT 47-57 peptide or TAT 47-57 -derived oligojugate was able to effectively silence the expression of CDK9 ‫%45ف(‬ and 82%, lanes 6 and 7, respectively) carbamate. A cysteine residue added to the amino terminus of TAT 47 Cells transfected with Cy3-SS/AS-3ЈTAT 47-57 EGFP RNAi activity, with CDK9 siRNA depending on conjugated TAT 47-57 for uptake and resulting RNAi activity. siRNA were tested at different concentrations for siRNA cellular uptake by measuring Cy3 fluorescence at 6 or
Altogether, these results demonstrate that siRNA covalently modified with TAT 47-57 can be effectively delivered 16 hr posttransfection. The measured fluorescence was then normalized to cells transfected with Cy3-SS/ASto cells and these siRNA-TAT conjugates successfully enter the RNAi pathway in cells to silence specific gene 3ЈTAT 47-57 EGFP siRNA using Lipofectamine. Cells transfected with the TAT peptide fused to siRNA exhibited expression. efficient siRNA cellular uptake that was enhanced by increasing both the amount of Cy3-SS/AS-3ЈTAT [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] Unnatural TAT-Derived Biopolymer Conjugated EGFP siRNA used per transfection and time postto siRNA Deliver siRNA to Cells for RNAi transfection (Figure 2A ; lanes 7 and 8 compared to lanes To increase the stability of siRNA-TAT peptides and to 5 and 6). The uptake of 150-300 nM Cy3-SS/AStest the possibility of attaching unnatural structures to 3ЈTAT 47-57 EGFP siRNA after16 hr (lane 7 and 8) was create functional siRNA, we synthesized a TAT-derived almost equal to uptake observed using 20 g of Lipofecoligocarbamate and conjugated to siRNA sequences tamine and 150 nM Cy3-SS/AS-3ЈN3 unconjugated (Figure 1 ). The oligocarbamate backbone consists of a EGFP siRNA (lane 1). Cells transfected with unconjuchiral ethylene backbone linked through relatively rigid gated Cy3-SS/AS-3ЈN3 EGFP siRNA plus free TAT [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] carbamate groups [47] . This modified TAT oligocarbapeptide or Cy3-SS/AS-3ЈHBFC siRNAs harboring only mate was previously shown to function similarly to wildthe HBFC linker without conjugated TAT 47-57 did not show type TAT peptides in TAR RNA binding experiments significantly measurable uptake of siRNA (lanes 2 and 4), and was resistant to proteinase K digestion [48] . After demonstrating that siRNA uptake did not occur without synthesis and purification, oligocarbamate was attached conjugated TAT [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] . These results indicated that siRNA to the siRNA using methods described above for TATcan be effectively delivered to cells by covalently modisiRNA conjugate preparation. Cy3-SS/AS-3ЈTAT 47-57 (carfying with TAT peptides. bamate) EGFP siRNA constructs were evaluated for To quantitatively determine the gene silencing funcsiRNA cellular uptake and associated RNAi activity. Celtion of TAT-conjugated siRNA sequences, we used a lular uptake of Cy3-SS/AS-3ЈTAT 47-57 (carbamate) EGFP dual fluorescence assay [5] . In this assay, SS/ASsiRNA was concentration and time dependent as ob-3ЈTAT 47-57 EGFP siRNA and plasmids harboring EGFP and red fluorescent protein (RFP) were transfected into served with TAT-siRNA conjugates (Figures 2A and 2B) . Figure 4A , the efficiency of siRNA uptake using 20-40 g/ml NP-45 (lanes 3 and 4) was almost equal to that measured for 20 g/ml Lipofectam- Figure 4B, lanes 4 and 5) . The RNAi activity measured using 400 or 1000 g/ml NP-45, however, was for effective and functional siRNA delivery. . siRNA transfected with 40 g/ml NP-45 also localized To visualize siRNA in cells and to determine a correlation between siRNA localization and function, we used Cy3-to perinuclear regions of the cytoplasm although it appeared to aggregate to more discrete areas within the labeled siRNA and delivered to HeLa cells by employing various approaches described above. Cy3-SS/AS-3ЈN3 perinuclear region ( Figure 5C ). Interestingly, using higher concentration of NP-45 (200 g/ml), a shift in siRNA EGFP siRNA localization was first established using Lipofectamine, and transfections were performed with or localization patterns was observed with cytoplasmic localization appearing more diffuse ( Figure 5D ). In addiwithout an EGFP reporter plasmid to determine whether siRNA localization was affected in the presence and tion, siRNA was observed in both the nucleus and nucleolus ( Figure 5D ), indicating that delivering siRNA to cells absence of the mRNA target. Transfected cells, live or stained with DAPI, were observed by confocal microsusing NP-45 at this higher concentration altered siRNA subcellular localization. It was not clear how NP-45 at copy, and Cy3-labeled siRNA localization was similar in live and fixed cells. siRNA localized to the cytoplasm higher concentrations was altering normal siRNA subcellular localization. However, these observations correaround the periphery of the nucleus, and this pattern was not altered by the presence of the EGFP reporter lated well to the lower RNAi activity associated with using higher concentrations of NP-45 and suggested construct ( Figures 5A and 5B) , indicating that siRNA localization was perinuclear and did not change in the that subcellular localization of siRNA was important for RNAi. presence of an mRNA target. , further concentration tested. There was also a distinct relationship between the concentration of the conjugate transsupport our findings of perinuclear siRNA localization in the cytoplasm. Our studies also showed that localizafected and siRNA uptake, with increasing concentrations resulting in increased uptake and RNAi activity. tion to these perinuclear regions was an important factor for efficient RNAi and suggested that RISC components Both NP-45 and the TAT 47-57 peptide conjugates showed this correlation between siRNA uptake and efficient may also localize to these perinuclear regions, creating a focal point for RNAi factories. RNAi. Analysis of the siRNA-TAT 47-57 -derived oligocarbamate conjugate revealed that altering the peptide backbone structure of the conjugate did not inhibit Significance siRNA uptake and these modified siRNAs-TAT 47-57 (carbamate) conjugates did not prevent the siRNA from en-RNA interference (RNAi) is the process by which short-interfering RNA (siRNA) target a specific mRNA tering the RNAi pathway to cause moderate RNAi. The moderate RNAi efficiency associated with these modifor degradation through interactions with an RNAinduced silencing complex (RISC). Because of its refied siRNA could be due to two reasons: (1) lower cellular siRNA uptake, and (2) the stabilized and protease-resismarkable potential for use in a myriad of laboratory and clinical applications, the mechanistic details of tant carbamate structure of TAT 47-57 peptide affected siRNA entry into the RNAi pathway. This raises the possiRNAi need to be further defined and effective methods for delivering siRNA to cells developed. Herein, a clear bility that siRNA was cleaved from unmodified TAT [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] peptide when introduced into cells, allowing released correlation between siRNA localization, siRNA uptake efficiency, and RNAi activity was discovered through siRNA to enter the RNAi pathway. Consistent with this possibility is the finding that the siRNA localization patdeveloping different approaches for delivering siRNA into cells. Our studies established that for functional terns of the unmodified and modified conjugates were virtually identical (Figure 6 ), suggesting that RISC dicRNAi, siRNA localization was distinctly perinuclear. Localization to these perinuclear regions was also tated siRNA localization instead of TAT 47-57 peptide. These results also suggested that the lower RNAi effihighly correlative to RNAi efficacy, suggesting that siRNA is targeted to these perinuclear regions for inciency observed with carbamate modification was asso- in ice-cold reporter lysis buffer (Promega) and 300 g of total cell sis. All siRNA were stored in DEPC-treated water at Ϫ80ЊC. The lysate in 160 l reporter lysis buffer was subject to fluorescence siRNA sequence targeting EGFP was from position 238-258 relative measurements using the PTI fluorescence spectrophotometer. Fluto the start codon [5] . For RNA interference targeting endogenous orescence of EGFP in the cell lysate was detected by exciting at gene CDK9, the sequence of CDK9-specific siRNA duplexes was 478 nm and emission spectrum was recorded from 498 to 650 nm. designed and subjected to a BLAST search against the human ge-
The spectrum peak at 507 nm represents the fluorescence intensity nome sequence to ensure only CDK9 gene was targeted. The siRNA of EGFP. Fluorescence of RFP in the same cell lysate was detected sequence targeting CDK9 was from position 258-278 relative to the be exciting at 568 nm and emission spectrum was recorded from start codon. Duplex siRNAs with 5Ј Cy3-modified sense strands 588 to 650 nm, and the spectrum peak at 583 nm represents the were used to determine the uptake efficiency of siRNA while duplex fluorescence intensity of RFP. The fluorescence intensity ratio of siRNAs with 3Ј amino modification were used in conjugating siRNA target (EGFP) to control (RFP) fluorophore was determined in the with TAT peptide as described below.
presence of siRNA and was normalized to that observed in the absence of siRNA. Normalized ratios Ͻ1 indicated specific interConjugating siRNA with TAT 47-57 Peptide ference. TAT 47-57 peptide with unmodified or oligocarbamate modified backbone (Cys- 47 Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg 57 ; 47-57 Cellular Uptake of siRNA by Nanoparticles amino acid sequence from wild-type TAT protein plus a cysteine HeLa cells were maintained at 37ЊC in Dulbecco's modified Eagles residue, which provides the free sulfhydryl group) were synthesized medium (DMEM, Invitrogen) supplemented with 10% fetal bovine by solid-phase synthesis as described previously [47] . Modified serum (FBS), 100 U/ml penicillin, and 100 g/ml streptomycin (InsiRNAs containing a 3Ј-amino group with a 3-carbon linker (3ЈN3) vitrogen). Cells were regularly passaged at subconfluence and were formed by annealing deprotected 3ЈN3 modified singleplated on 60 mm plates 16 hr before transfection at 70% confluency. stranded siRNA with its complementary strand sequences. 25 nmol 21 nt 5Ј-Cy3-labeled EGFP sense strand siRNA was deprotected, duplex siRNA with 3ЈN3 modification were then incubated with 50-annealed to unmodified antisense strand siRNA, and purified as fold molar excess of a heterobifinctional crosslinker (HBFC), sulfodescribed above. As a control, Lipofectamine-mediated transfecsuccinimidyl 4-(p-maleimidophenyl)-butyrate, in 400 l PBS reaction tions were performed as described by the manufacturer for adherent buffer (20 mM sodium phosphate, 150 mM NaCl, pH 7.2). After cell lines. For siRNA delivery by nanoparticles, we used a generation shaking for 1 hr at room temperature, the reaction products were four polyamidoamine dendrimer that had 64 surface groups and a separated by a reverse-phase column. The fractions containing the diameter of 45 Å . Here, we denote these particles as NP-45. We activated siRNA-crosslinker were pooled and incubated with an transfected cells with Cy3-SS/AS-3ЈN3 EGFP siRNA and NP-45 as equal molar ratio of TAT 47-57 peptide at room temperature for 1 hr. described above. Cells were incubated in transfection mixture for A cysteine residue added to the amino terminus of TAT 47-57 peptide 6 hr and washed three times with PBS (Invitrogen) to remove the or TAT 47-57 -derived oligocarbamate was used for siRNA conjugation. transfection mixture. Total DNA, RNA, and the transfected Cy3-SS/ The reaction was then quenched by addition of reaction buffer con-AS-3ЈN3 EGFP siRNA were isolated from the cells and subjected to taining 50 mM cysteine. TAT 47-57 peptide conjugates were analyzed fluorescence measurements on the PTI fluorescence spectrophoand purified by 20% nondenaturing polyacrylamide gel electrophotometer as described above. resis. siRNA conjugated to TAT 47-57 peptide and carbamate exhibited retarded mobility when compared to unmodified duplex siRNA. 
